Nxera Pharma Co Ltd
TSE:4565
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nxera Pharma Co Ltd
TSE:4565
|
JP |
|
Eni SpA
MIL:ENI
|
IT |
|
P
|
Pureun Mutual Savings Bank
KOSDAQ:007330
|
KR |
|
Persimmon PLC
LSE:PSN
|
UK |
|
H
|
Hyunwoo Industrial Co Ltd
KOSDAQ:092300
|
KR |
|
A
|
Apollomics Inc
NASDAQ:APLM
|
US |
|
G
|
Groep Brussel Lambert NV
SWB:EAI
|
BE |
|
H
|
Halliburton Co
DUS:HAL
|
US |
|
M
|
Mondo TV SpA
SWB:MJE
|
IT |
|
Eurocash SA
F:E07
|
PL |
|
D
|
Dewan Cement Ltd
KAR:DCL
|
PK |
|
ImmuCell Corp
NASDAQ:ICCC
|
US |
|
Williams-Sonoma Inc
NYSE:WSM
|
US |
|
Central Japan Railway Co
OTC:CJPRF
|
JP |
|
R
|
Raubex Group Ltd
JSE:RBX
|
ZA |
|
S
|
Southwest Airlines Co
F:SWN
|
US |
Dividends
Dividend Yield
Nxera Pharma Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Nxera Pharma Co Ltd
Payout Ratio
Nxera Pharma Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Nxera Pharma Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Nxera Pharma Co Ltd
| Average Annual Return | -4.17% |
| Standard Deviation of Annual Returns | 33.93% |
| Max Drawdown | -78% |
| Market Capitalization | 111.7B JPY |
| Shares Outstanding | 92 610 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Nxera Pharma Co Ltd's latest stock split occurred on Jun 27, 2018
The company executed a 4-for-1 stock split, meaning that for every share held, investors received 4 new shares.
Before the split, Nxera Pharma Co Ltd traded at 6940 per share. Afterward, the share price was about 1792.
The adjusted shares began trading on Jun 27, 2018. This was stock split number 2 in Nxera Pharma Co Ltd's history, following the previous one in Mar 27, 2013.